Connect & Solve
Trade Q&A
What compliance risks and core customs clearance challenges can agency import of medical products avoid?
Resolved
SERVICE
TRACKING NO. 20260427 / GLOBAL Zhongshen Trade · 23+ Years of Expert Trade Agency
Trade Challenges?
No import/export license, customs delays,
or complex compliance issues.
or complex compliance issues.
Our Solution
One-stop full-chain agency: ensure efficient
clearance and fund security.
clearance and fund security.
Cost OptimizationUrgent ClearanceGlobal ResourcesCompliant Rebates
I am the head of a domestic medical device distributor. Last week, I finalized a purchase order for a batch of minimally invasive surgical instruments with a German supplier. I recalled that when I imported similar products last year, my shipment was detained at customs for a full 62 days due to incomplete documents for the medical device import registration certificate. I not only paid 80,000 yuan in liquidated damages to my client but also incurred over 30,000 yuan in demurrage fees. Now I want to use a foreign trade agency to handle the import, but I’m not confident: Can agency import of medical products really avoid such compliance risks? Will it actually increase my procurement costs? And if there is an abnormal customs inspection, can the agency provide solutions immediately? I’m anxious and afraid of falling into the same trap again, so I just want to clarify these questions.
Michael ZhangYears of service：6Customer Rating：5.0
Customs Declaration & Compliance ExpertStart a Chat
First，we need to expose common industry misconceptions: Many enterprises mistakenly believe that holding basic documents provided by suppliers will allow smooth customs clearance，but they ignore the validity review of the core *Medical Device Import Registration Certificate* for medical product imports. For example，a registration certificate with less than 6 months of validity left，or whose coverage does not match the imported product models，are all hidden landmines.
The chain of negative reactions caused by such misconceptions can easily escalate: At best，goods will be detained at the port，with daily container demurrage and storage fees reaching several thousand yuan. If the issue is not resolved within 14 days，the customs will initiate a mandatory clearance and repatriation procedure，at worst，the goods will be directly detained. Enterprises will not only bear the full cost of return shipments but may also be added to the customs credit warning list for violating medical device supervision regulations，affecting all subsequent import businesses.
Physical risk isolation measures need to be taken in advance: When selecting an agency，require it to initiate a full document review 30 days in advance，focusing on checking the matching degree of the registration certificate’s product models，its validity period，and the medical device production qualification certificates of overseas suppliers，to ensure all materials comply with the latest customs regulatory requirements for medical product imports in 2026.
Exclusive loss mitigation tip: Sign a compliance customs clearance indemnity clause with the agency，clearly stating that if the agency’s document review error leads to customs detention or port demurrage，the agency shall bear direct losses such as demurrage fees and repatriation costs，at the same time，require the agency to connect to the local customs medical product green channel in advance，so that the review and recheck process can be initiated with priority when abnormalities occur.
Jason WuYears of service：10Customer Rating：5.0
International Logistics & Supply Chain ManagerStart a Chat
When declaring medical products for import, special attention should be paid to the rationality of related party transaction pricing in the customs valuation link. The customs’ reference database for medical product valuation has been updated in 2026, adding dimensions such as ex-factory prices of medical devices from major origins including the EU and the United States, and cross-border transportation costs. If the declared price deviates by more than 15% from the database’s reference price, it will trigger valuation questioning, and supporting materials such as purchase contracts, supplier cost details, and payment vouchers must be provided. In addition, the customs declaration code for medical products must be accurately matched. For example, minimally invasive surgical instruments need to be distinguished between “reusable” and “single-use”. Incorrect codes will directly lead to return of declaration or customs detention. It is recommended to entrust a professional institution to conduct a pre-classification review 3 days in advance.
Linda GaoYears of service：7Customer Rating：5.0
Documentation SupervisorStart a Chat
Medical products, especially minimally invasive surgical instruments, are high-precision devices, so international logistics routes should prioritize direct shipping routes. In 2026, Shanghai Port launched an exclusive direct shipping route for medical products to Hamburg Port, which shortens the voyage by 7 days compared to transshipment routes, reducing the risk of damage to devices caused by transshipment and handling. At the same time, it is necessary to clarify the cargo right control clause in the bill of lading, choose “order bill of lading” and require the agency to conduct full cargo right monitoring, to avoid situations where the supplier privately retains the bill of lading or there is an abnormal transfer of cargo rights. In addition, the free storage period at the port of destination should be confirmed in advance. The free storage period for medical products at Shanghai Port can be extended to 14 days upon application, and a copy of the Medical Device Import Registration Certificate must be submitted 3 days before the arrival of the goods.
Lucas LiuYears of service：8Customer Rating：5.0
Senior Operations ConsultantStart a Chat
In 2026, medical product imports can enjoy the VAT deferment policy, without paying full value-added tax at the import link, and the tax payment can be deferred until after the product is sold, effectively alleviating the enterprise’s cash flow pressure. In addition, if the enterprise is a high-tech enterprise, it can apply for exemption from import tariffs and import value-added tax for imported eligible medical research and development devices, but the *Confirmation Letter for Encouraged Domestic and Foreign-funded Projects* must be submitted to the customs in advance. At the same time, attention should be paid to the pricing compliance of cross-border related party transactions, to avoid triggering anti-tax avoidance investigations by tax authorities due to unreasonable transfer pricing. It is recommended to conduct a compliance audit of related party transaction pricing every year.
Andy GuoYears of service：3Customer Rating：5.0
Supply Chain Management ExpertStart a Chat
Cross-border receipts and payments for medical product imports must strictly match the “four-stream consistency”, that is, the contract flow, capital flow, invoice flow, and cargo flow must fully correspond. In 2026, the People’s Bank of China has included the receipts and payments review for medical device imports in special monitoring. If the capital flow deviates by more than 10% from the contract amount, it will trigger early warning and verification by the State Administration of Foreign Exchange. It is recommended to choose the CIPS (Cross-border Interbank Payment System) for payment, which can not only reduce exchange loss but also shorten the arrival time to within 24 hours. In addition, if advance payment is involved, materials such as the purchase contract and Medical Device Import Registration Certificate must be submitted to the SAFE for filing before payment, to avoid the situation where the payment is frozen.
Cindy ChenYears of service：3Customer Rating：5.0
Key Account ManagerStart a Chat
When signing a contract with an agency company, it is necessary to clarify the compliance indemnity clause for medical device imports, especially the division of liability for situations such as the expiration of the *Medical Device Import Registration Certificate* and products not meeting Chinese regulatory standards, to avoid the agency shirking its responsibilities. In addition, attention should be paid to the “force majeure clause” in the contract provided by overseas suppliers, and it is necessary to add an agreement that “customs clearance abnormalities caused by the supplier’s failure to provide compliant documents do not fall under force majeure”, to prevent the supplier from evading responsibility on this grounds. At the same time, it is recommended to file intellectual property customs protection for imported medical products, to avoid the situation where infringing products are detained at customs.
Kevin LinYears of service：4Customer Rating：5.0
Trade Solutions ManagerStart a Chat
When medical products are inspected by customs, the original documents such as the *Medical Device Import Registration Certificate*, product manuals, and certificate of origin must be prepared in advance. In 2026, Shanghai Port Customs has added a “non-contact inspection” option for medical product inspections, which can review product details through high-definition cameras without opening the boxes, avoiding damage to high-precision devices. If the customs requires unpacking inspection, professional personnel should be arranged to be present to cooperate with customs personnel in product identification, to avoid device damage caused by improper operation. In addition, if a laboratory test is required after inspection, the test application must be submitted within 3 days, and the agency can be entrusted to connect to the third-party laboratory designated by the customs, shortening the test cycle to 7 days.
Grace WangYears of service：10Customer Rating：5.0
Senior Foreign Trade ConsultantStart a Chat
Minimally invasive surgical instruments are high-precision and easily damaged medical products, so the transportation packaging must comply with the UN3373 biosafety packaging standards. In 2026, customs has included packaging review for medical products in the pre-customs clearance link. If the packaging does not meet the standards, the goods will be directly returned to the place of shipment. The packaging should adopt a three-layer buffer structure: the inner layer uses anti-static foam to wrap the instruments, the middle layer uses waterproof PE bags for sealing, and the outer layer uses hard cartons for reinforcement and marked with “fragile” and “medical products” and other labels. In addition, MSDS (Material Safety Data Sheet) must be provided with the shipment. If the instruments contain metal parts, the material and anti-rust treatment method must be clearly marked, to avoid port detention due to non-compliant packaging.
Victor SunYears of service：5Customer Rating：5.0
Trade Risk Control ManagerStart a Chat
When importing medical products through an agency, the supply chain cost can be optimized through the “inventory linkage strategy”, that is, according to the order demand of domestic customers, agree with the agency to import goods in batches, avoiding inventory backlog caused by importing a large number of products at one time. In 2026, Shanghai Port launched a “bonded warehouse + batch customs clearance” service for medical products, which allows imported products to be stored in bonded warehouses and go through customs clearance procedures in batches according to sales orders, effectively reducing the cost of inventory capital occupation. In addition, trade terms should be optimized, and it is recommended to choose CIF trade terms, so that the agency is responsible for international transportation and insurance, which can transfer transportation risks to the agency and reduce the enterprise’s logistics management costs.